Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cell MedX Corp
CMXC
Healthcare
Medical Devices
Medical Instruments & Supplies
Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company...
, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:CMXC)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Jan 24, 2017 6:20pm
Cell MedX Corp. Receives Approval from Health Canada to Comm
Cell MedX Corp. Receives Approval from Health Canada to Commence its Observational Clinical Trial in Canada CARSON CITY, NV / ACCESSWIRE / January 23, 2017 / Cell MedX Corp. (CMXC), Cell MedX Corp.
...more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Jan 10, 2017 10:01am
Cell MedX Corp. Receives Data from Observational Trials in M
CARSON CITY, NV / ACCESSWIRE / January 10, 2017 / Cell MedX Corp. (CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), announces that it has received more positive observational results from our
...more
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Jan 09, 2017 8:51am
Cell MedX Corp. Receives First Commercial eBalance Pro Welln
Cell MedX Corp. Receives First Commercial eBalance Pro Wellness Devices Carson City, Nevada, January 9, 2017, Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), is
...more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Dec 13, 2016 9:03am
Cell MedX (CMXC) Widens Scope for Breakthrough Technology
By RYAN ALLWAY December 13th, 2016 Source: SECFilings.com Cell MedX Corp. (OTCQB: CMXC), a development-stage biotech company focused on harnessing the power of microcurrent technologies to address
...more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Nov 29, 2016 9:33am
Cell MedX (CMXC) Advances the Power of Microcurrents
Microcurrent therapy uses extremely low-level electrical currents that promote general wellness and alleviate complications associated with certain medical conditions. On a cellular level, the
...more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Nov 21, 2016 8:47am
Cell MedX Corp. Appoints Gregory Pek to the Advisory Board
Cell MedX Corp. Appoints Gregory Pek to the Advisory Board and as a Distributor LAS VEGAS, NV--(Marketwired - Nov 21, 2016) - Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX"
...more
(0)
•••
Tamarack
X
View Profile
View Bullboard History
Post by
Tamarack
on Nov 03, 2016 1:19pm
Cell MedX Corp. (CMXC) Engages Tamarack Advisors
DENVER, CO / ACCESSWIRE / November 3, 2016 / Cell MedX Corp. (CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a development stage company focused on the commercialization of
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth